Abstract
Further optimization of an initial DP2 receptor antagonist clinical candidate NVP-QAV680 led to the discovery of a follow-up molecule 2-(2-methyl-1-(4-(methylsulfonyl)-2-(trifluoromethyl)benzyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid (compound 11, NVP-QAW039, fevipiprant), which exhibits improved potency on human eosinophils and Th2 cells, together with a longer receptor residence time, and is currently in clinical trials for severe asthma.
References
Feb 24, 2001·The Journal of Experimental Medicine·H HiraiK Nagata
Apr 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Kang ChengM Gerard Waters
Sep 29, 2011·Bioorganic & Medicinal Chemistry Letters·Tim LukerStephen Thom
Aug 3, 2012·The Journal of Pharmacology and Experimental Therapeutics·David A SykesSteven J Charlton
Nov 28, 2012·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Robert G Townley, Swati Agrawal
Sep 12, 2013·Bioorganic & Medicinal Chemistry·David A SandhamCaroline Wilson
Oct 1, 2013·Expert Opinion on Investigational Drugs·Peter Norman
Nov 2, 2013·Allergy, Asthma & Immunology Research·Pernille Munk FrandsenPeter Oluf Schiøtz
Jan 7, 2014·The Journal of Allergy and Clinical Immunology·Luzheng XueGraham Ogg
Dec 2, 2014·Bioorganic & Medicinal Chemistry Letters·Miriam AndrésRichard S Roberts
Dec 2, 2014·Bioorganic & Medicinal Chemistry Letters·Juan Antonio AlonsoMiriam Zanuy
Dec 2, 2014·Bioorganic & Medicinal Chemistry Letters·Juan Antonio AlonsoMiriam Zanuy
Dec 2, 2014·Bioorganic & Medicinal Chemistry Letters·Juan Antonio AlonsoPere Vilaseca
Feb 27, 2016·Molecular Pharmacology·David A SykesSteven J Charlton
May 1, 2016·Lancet·Sally WenzelAriel Teper
Jun 17, 2016·Clinical Pharmacology in Drug Development·Veit J ErpenbeckMarkus Weiss
Jun 19, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Marta CalbetMontserrat Miralpeix
Jun 30, 2016·Pulmonary Pharmacology & Therapeutics·Veit J ErpenbeckJutta Beier
Aug 10, 2016·The Lancet. Respiratory Medicine·Sherif GonemChristopher E Brightling
Citations
Nov 1, 2018·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Revital ShamriFrancesca Levi-Schaffer
Jul 30, 2019·Allergy·Christopher E BrightlingPablo Altman
Oct 23, 2019·Signal Transduction and Targeted Therapy·Seyyed Shamsadin Athari
Nov 27, 2019·Pharmacological Reviews·Stacy Gelhaus WendellCheng Zhang
Oct 1, 2018·Respiratory Research·Christian DomingoPablo Altman
Sep 21, 2019·Combinatorial Chemistry & High Throughput Screening·Abdul R IssahakuMahmoud E S Soliman
Sep 28, 2020·The Lancet. Respiratory Medicine·Christopher E BrightlingEugene R Bleecker
Nov 5, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Corrado PelaiaGirolamo Pelaia
Oct 18, 2020·Signal Transduction and Targeted Therapy·Seyyed Shamsadin Athari
Apr 8, 2021·Pulmonary Pharmacology & Therapeutics·Chris BrightlingPablo Altman
Mar 3, 2019·The Journal of Allergy and Clinical Immunology·Clare HardmanGraham Ogg
May 21, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wentao ChenLuzheng Xue
Jul 15, 2021·Nature Reviews. Drug Discovery·Jian Payandeh, Matthew Volgraf
Aug 3, 2021·Frontiers in Physiology·Bohae Rachel LeeNeelam Sharma-Walia
Oct 9, 2021·Respiratory Research·Saskia CarstensenMeike Müller